600993.SS
600993.SS
CNE000001HN2
MAYINGLONG PHARMACEUTICAL GP CO
Loading chart...

Company Profile

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. It operates through three segments: Pharmaceutical Manufacturing; Pharmaceutical Wholesale and Retail; and Medical Services. The company offers functional cosmetics, care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells pharmaceutical packaging materials, cosmetics, and Chinese medicines; produces and sells health food; and offers class I and II medical devices, machinery, household goods, electronic products, daily necessities, hygiene products, and disinfection products, as well as road freight transportation services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.

Related stocks

600812.SS
600812.SS • China
NORTH CHINA PHARMACEUTICAL CO
6.03 CNY
1.55B USD 1Y +1.5%
600572.SS
600572.SS • China
ZHEJIANG CONBA PHARMACEUTICAL C
4.41 CNY
1.68B USD 1Y +0.5%
002099.SZ
002099.SZ • China
HISOAR
6.32 CNY
1.53B USD 1Y +8%
002332.SZ
002332.SZ • China
XJZY
8.76 CNY
1.3B USD 1Y -11.2%
600789.SS
600789.SS • China
SHANDONG LUKANG PHARMACEUTICAL
8.28 CNY
1.29B USD 1Y -15.3%
600211.SS
600211.SS • China
TIBET RHODIOLA PHARMACEUTICAL H
36.78 CNY
1.77B USD 1Y -22.9%
300026.SZ
300026.SZ • China
CHASE SUN PHARM.
3.32 CNY
1.49B USD 1Y -10.8%
600129.SS
600129.SS • China
CHONGQING TAIJI IND
13.97 CNY
1.15B USD 1Y -36.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
31.0% p.a.
Max Drawdown (5Y)
-37.5%
Sharpe Ratio (5Y)
-0.16
Beta Factor
0.21
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.0% p.a.).
ende